2007-5936 2007-5936 S2007-59362024000100112 10.36793/psicumex.v14i1.628 Mexico Mexico Mexico Mexico Mexico Mexico 00 12 2024 00 12 2024 14

1970 1999 21 ^s2 Suppl ^s2 Suppl 2 Suppl 16S-23S American Psychiatric Association 2013 5th ed 2022 56 11-12 11-12 1532-42 2014 37 5 5 373-80 2015 36 219-32 1995 10 2 2 89-97 External Review Panel 2023 9 2 2 2021 3 1 1 1-12 2020 24 2 2 4 2024 2016 126 74-88 2021 384 15 15 1402-11 2016 3 7 7 619-27 2017 7 1 1 2018 235 2 2 399-408. 2015 30 1 1 42-9 2021 12 2023 32 9 9 937-42 2018 16 4 4 420-9 2010 8 4 4 478-94 2000 10 4 4 185-9 2021 38 11 11 1120-30 2023 13 7 7 2016 126 89-101 2021 35 4 4 453-8 2012 62 1 1 35-41 2003 53 8 8 649-59 Food and Drug Administration 2019 2021 33 2 2 121-32 2017 40 3 3 129-35 2015 131 77-86 2021 26 5 5 2023 22 1 1 116 2022 387 18 18 1637-48 2021 39 6 6 653-65 2006 187 3 3 268-83 2016 30 12 12 1181-97 2011 68 1 1 71-8 2021 9 2019 17 2 2 108-28 2023 13 2 2 2003 25 2 2 150-68 2022 93 3 3 215-23 2023 342 1 1 139-47 1999 2 2 2 81-7 2022 2016 126 68-73 2023 32 9 9 1452-60 2022 387 18 18 1708-9 1971 118 543 543 229-30 2016 2018 157 258-65 2020 10 2020 276 1 1 576-84 2012 169 1 1 89-94 2014 71 2 2 128-35 2008 6 1 1 63-80 2021 3 1 1 5 2004 101 2 2 131-81 2022 30 2 2 1181-90 Organización Mundial de la Salud 2021 Organización Mundial de la Salud 2021 2019 49 4 4 655-63 2005 12 1 1 77-85 Pew Research Center 2022 2022 47 1 1 225-46 2020 72 6 6 1562-72 2021 Primera ed Grupo de Neurociencias de la Universidad Nacional Autónoma de México 2019 50 8 8 518-26 2011 44 3 3 449-64 Novel Treatments, a. D. o. t. A. P. A. C. o. R 2020 177 5 5 391-410 2011 13 1 1 101-108. 2016 30 12 12 1165-80 2021 38 4 4 456-67 2014 2 121-59 2020 276 626-35 2016 36 1 1 77-81 2021 13 8 8 2022 36 3 3 258-72 2021 10 17 17 2023 11 1 1 256 2023 25 1 1 50-63 2008 313-33 2021 196 2008 11 9 9 1268-71 2018 9 2017 73 359-78 2023 121 2018 175 2 2 150-8 2011 14 5 5 537 2006 63 8 8 856-64